Chloe Karpinskyj

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Ian Jacobs, Usha Menon, Andy Ryan et al. · The Lancet · 2015 · 1.1K citations · Full text

Medicine, Gynecology, Oncology +14

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Usha Menon, Aleksandra Gentry‐Maharaj, Matthew Burnell et al. · The Lancet · 2021 · 700 citations · Full text

Medicine, Gynecology, Oncology +17

Dose-Response Association of CD8⁺ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli et al. · JAMA Oncology · 2017 · 404 citations · Full text

Medicine, Immunology, Oncology +17

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study

Peter Rambau, Robert A. Vierkant, Maria P. Intermaggio et al. · The Journal of Pathology Clinical Research · 2018 · 100 citations · Full text

Medicine, Oncology, Pathology +17

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

Nicola S. Meagher, Linyuan Wang, Peter Rambau et al. · Modern Pathology · 2019 · 99 citations · Full text

Medicine, Oncology, Pathology +16